Picture of Atreca logo

BCEL Atreca Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Atreca, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-37.9-67.5-86.3-109-97.2
Depreciation
Non-Cash Items1.455.512.818.419
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.3781.754.4925.4-8.04
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-34.7-58.5-66.7-60.9-80.7
Capital Expenditures-1.76-3.45-5.03-35.1-0.885
Purchase of Fixed Assets
Other Investing Cash Flow Items22.4-24.5-15412413.4
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities20.7-27.9-15989.212.5
Financing Cash Flow Items-2.85-0.6330
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1201311295.453.9
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash10644.7-96.833.8-64.3